ExploreWatchlistsPricing
  1. JP-listed companies
  2. ADR120S, Inc.
  3. Financials
  4. Total non-current liabilities

ADR120S, Inc. (3750)

Market cap
¥7.3B
P/E ratio
101.4x
Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 20252,415-2.79%
Mar 31, 20242,485-75.79%
Mar 31, 202310,261-9.15%
Mar 31, 202211,295+6.15%
Mar 31, 202110,641-1.82%
Mar 31, 202010,837+261.41%
Mar 31, 20192,999+6907.55%
Mar 31, 201843+827.44%
Mar 31, 20175-25.05%
Mar 31, 20166-70.93%
Mar 31, 201521

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat